Welcome to our dedicated page for THERMO FISHER SCIENTIFIC SEC filings (Ticker: TMO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on THERMO FISHER SCIENTIFIC's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into THERMO FISHER SCIENTIFIC's regulatory disclosures and financial reporting.
Thermo Fisher Scientific Inc. reported the results of shareholder voting from its May 20, 2026 annual meeting. All nominated directors were elected, each receiving substantially more votes "For" than "Against." For example, Debora L. Spar received 314,426,121 votes for and 311,821 against.
A key outcome was that a non-binding, advisory proposal on the compensation of the company’s named executive officers was not approved, with 99,928,178 votes for and 214,525,673 against. Shareholders also ratified the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, by 296,866,709 votes for and 36,064,900 against.
Thermo Fisher Scientific director Dion J. Weisler received a grant of 499 shares of Common Stock, increasing his direct holdings. On the same date, 80.287 shares were withheld at $451.79 per share to satisfy tax obligations related to this award, leaving him with 5,446.384 directly held shares.
Thermo Fisher Scientific director Scott M. Sperling received an award of 499 shares of Common Stock at no cost, classified as a grant or other acquisition. After this compensation grant, he directly holds 69,479 shares of Thermo Fisher Scientific common stock.
Spar Debora L reported acquisition or exercise transactions in this Form 4 filing.
THERMO FISHER SCIENTIFIC INC. director Debora L. Spar reported receiving a grant of 499 shares of Common Stock on May 20, 2026. The award carried a stated price of $0.00 per share, indicating compensation rather than an open-market purchase. After this grant, she directly holds 2,610 shares of Thermo Fisher stock, reflecting a routine equity compensation transaction rather than a market trade.
Lynch Karen S reported acquisition or exercise transactions in this Form 4 filing.
THERMO FISHER SCIENTIFIC INC. director Karen S. Lynch reported a stock award of 499 shares of common stock on May 20, 2026, recorded at $0.0000 per share. After this grant, she directly owns 1,159 common shares. The filing also reports 76 additional common shares held indirectly through a living trust.
Keith R. Alexandra reported acquisition or exercise transactions in this Form 4 filing.
Thermo Fisher Scientific director Keith R. Alexandra received a stock grant of 499 shares of Common Stock as compensation, not an open-market purchase. The shares were awarded at a stated price of $0.00 per share, increasing his directly held position to 2,602 shares following the transaction.
JOHNSON JENNIFER M reported acquisition or exercise transactions in this Form 4 filing.
Thermo Fisher Scientific director Jennifer M. Johnson reported receiving a grant of 499 shares of Common Stock on May 20, 2026. The award was recorded at a price of $0.00 per share, indicating it was part of her director compensation rather than an open-market purchase. After this grant, she directly holds a total of 1,403 shares of Thermo Fisher Scientific common stock.
Jacks Tyler reported acquisition or exercise transactions in this Form 4 filing.
THERMO FISHER SCIENTIFIC INC. director Tyler Jacks received a grant of 499 shares of common stock on May 20, 2026. The award was granted at no cash cost per share and increased his directly held position to 9,462 shares. This is a routine compensation-related equity grant rather than an open-market purchase.
HARRIS C MARTIN reported acquisition or exercise transactions in this Form 4 filing.
Thermo Fisher Scientific director Harris C. Martin received a grant of 499 shares of Common Stock on May 20, 2026 at no cash cost. This compensation-related award increased his direct holdings to 9,532 shares. The filing does not report any open-market buying or selling.
THERMO FISHER SCIENTIFIC INC. director Ruby R. Chandy received a grant of 499 shares of Common Stock on May 20, 2026 at no cost as compensation. Following this award, Chandy directly holds 3,463 shares, indicating a routine, non-market acquisition rather than an open-market purchase or sale.